Skip to content
  • Tuesday, 27 October 2026
  • 9:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Paradigm-Shifting Discovery Reveals Immune Cells as the Primary Driver of Alzheimer’s-Related Sleep Disruption
Neuroscience & Brain Research

Paradigm-Shifting Discovery Reveals Immune Cells as the Primary Driver of Alzheimer’s-Related Sleep Disruption

Rifan Muazin Oct 27, 2026 0

In a significant departure from decades of established medical consensus, researchers at the University of Kentucky have identified a novel…

Read More
Neuroscience & Brain Research

Beyond the 10,000 Steps: How Modest Physical Activity Could Hold the Key to Preventing Alzheimer’s Disease

Rifan Muazin Oct 26, 2026 0

For decades, the standard medical advice for maintaining brain health has been tethered to the ambitious goal of 10,000 steps…

Read More
Neuroscience & Brain Research

Genetic Shield Against Alzheimer’s Disease Identified by Columbia Researchers Offers New Path for Therapeutic Innovation

Rifan Muazin Oct 26, 2026 0

For decades, the medical community has grappled with an enduring paradox: why do some individuals, despite possessing the APOE ε4…

Read More
Neuroscience & Brain Research

Scientists find a way to fight Alzheimer’s brain damage without removing toxic tau

Rifan Muazin Oct 25, 2026 0

For decades, the central dogma of Alzheimer’s research has focused on the "protein-first" hypothesis. Scientists have tirelessly pursued methods to…

Read More
Neuroscience & Brain Research

Groundbreaking Autopsy Study Provides Definitive Evidence Linking Amyloid Clearance to Reduced Alzheimer’s Pathology

Rifan Muazin Oct 16, 2026 0

In a landmark case study that has sent ripples through the neurological community, researchers from the Perelman School of Medicine…

Read More
Neuroscience & Brain Research

Beyond Amyloid Beta: A New Frontier in Alzheimer’s Disease Research Challenges Decades of Scientific Dogma

Rifan Muazin Oct 15, 2026 0

For over thirty years, the global scientific community has operated under a monolithic paradigm regarding the pathogenesis of Alzheimer’s disease,…

Read More
Neuroscience & Brain Research

Gut Microbiome Discovery Links Imidazole Propionate to Accelerated Alzheimer’s Disease Progression

Rifan Muazin Oct 12, 2026 0

A groundbreaking investigation led by researchers at the University of Wisconsin-Madison has identified a critical biological link between the human…

Read More
Neuroscience & Brain Research

Mount Sinai Researchers Identify Reversible Vascular and Cellular Drivers of Alzheimer’s Disease Risk Linked to APOE4 Gene

Rifan Muazin Oct 10, 2026 0

Mount Sinai researchers have fundamentally reshaped the scientific understanding of Alzheimer’s disease by uncovering how the APOE4 gene—the most significant…

Read More
Neuroscience & Brain Research

Unlocking the 3D Genome: A New Frontier in Understanding Alzheimer’s Disease Pathogenesis

Rifan Muazin Oct 5, 2026 0

A collaborative team of researchers from Carnegie Mellon University (CMU), the University of Pittsburgh (Pitt), and the University of Washington…

Read More
Neuroscience & Brain Research

Gut-Derived Molecule Imidazole Propionate Identified as Potential Catalyst for Alzheimer’s Disease Progression and Cognitive Decline

Rifan Muazin Oct 3, 2026 0

A growing body of medical research has increasingly pointed toward the human digestive tract as a vital, albeit complex, player…

Read More

Posts pagination

1 2 … 11
Molecular Catapults and Quantum Speed: How Cambridge Researchers Redefined Electron Transfer in Solar Energy HarvestingEx-NFL Player Convicted in $328M Genetic Testing Fraud as Medicare Scrutiny IntensifiesRecordati Weighs CVC’s €10.9 Billion Acquisition Offer, Potentially Delisting from Italian Stock ExchangeThe oral exposure challenge in PROTACs: What drug developers need to solve early
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ